Possible Modulation of Glycated Protein Levels in Prehypertension by Lipid Peroxides

REFERENCES

• Chobanian AV, Bakris GR, Black HR, ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682–1686.
   PubMed Web of Science ®Google Scholar
• Das SK, Sanyal K, Basu A. Study of urban community survey in India: growing trend to high prevalence of hypertension in a developing country. Int J Med Sci 2005; 2:70–78.
   PubMedGoogle Scholar
• Thornalley PJ. Clinical significance of glycation. Clin Lab 1999; 45:263–273.
   Google Scholar
• Lapolla A, Traldi P, Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 2005; 38:103–115.
   PubMed Web of Science ®Google Scholar
• Mayer TK, Freedman ZR. Protein glycosylation in diabetes mellitus: a review of laboratory measurements and of their clinical utility. Clin Chim Acta 1983; 127:147–184.
   PubMed Web of Science ®Google Scholar
• Chowdhury TA, Lasker SS. Elevated glycated hemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J 1998; 74:480–481.
   PubMed Web of Science ®Google Scholar
• Selvaraj N, Bobby Z, Sridhar MG. Increased glycation of hemoglobin in chronic renal failure: potential role of oxidative stress. Arch Med Res 2008; 39:277–284.
   PubMed Web of Science ®Google Scholar
• Nilsson PM, Lind L, Pollare T, Berne C, Litthell HO. Increased concentration of hemoglobin A1C, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 1995; 44:557–561.
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the concentrations of hemoglobin A1C in nondiabetic patients. Acta Haematol 2004; 112:126–128.
   PubMed Web of Science ®Google Scholar
• Cecchin E, De Marchi S, Panarello G, De Angelis V. Rheological abnormalities of erythrocyte deformability and increased glycosylation of hemoglobin in nephrotic syndrome. Am J Nephrol 1987; 7:18–21.
   PubMed Web of Science ®Google Scholar
• Sabater J, Quereda C, Herrera I, Pascual J, Villafruela JJ, Ortuno J. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal failure. Am J Nephrol 1991; 11:37–43.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Garcia J, Requena JR, Rodriguez-Segade S. Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin Chem 1998; 44:250–255.
   PubMed Web of Science ®Google Scholar
• Roberts RN, Traub AI, Kennedy AL, Hadden DR. Glycosylated haemoglobin and hypertension arising in pregnancy. Br J Obest Gynaecol 1998; 105:1122–1124.
   PubMedGoogle Scholar
• Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Agrawal A, Pavithran P. Enhanced glycation of hemoglobin and plasma proteins is associated with increased lipid peroxides levels in non-diabetic hypertensive subjects. Arch Med Res 2007; 38:822–826.
   PubMed Web of Science ®Google Scholar
• Jain SK, Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 1997; 22:593–596.
   PubMed Web of Science ®Google Scholar
• Selvaraj N, Bobby Z, Sridhar MG. Oxidative stress: does it play a role in the genesis of early glycated proteins? Med Hypotheses 2008; 70:265–268.
   PubMed Web of Science ®Google Scholar
• Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta 2005; 366:190–195.
   PubMed Web of Science ®Google Scholar
• Wang X, Desai K, Juurlink BH, de Champlain J, Wu L. Gender-related differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats. Kidney Int 2006; 69:281–287.
   PubMed Web of Science ®Google Scholar
• Wu L, Juurlink BH. Increased methylglyoxal and oxidative stress in hypertensive rat vascuale smooth muscle cells. Hypertension 2002; 39:809–814.
   PubMed Web of Science ®Google Scholar
• Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens 2005; 23:1565–1573.
   PubMed Web of Science ®Google Scholar
• Satoh K. Serum lipid peroxide in cardiovascular disorder determined by a new colorimetric method. Clin Chim Acta 1978; 90:37–43.
   PubMed Web of Science ®Google Scholar
• O. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47:412–426.
   PubMedGoogle Scholar
• Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Economou M, Papadimitriou L, Stefanadis C. The association between pre-hypertension status and oxidative stress markers related to atherosclerosis disease: the ATTICA study. Atherosclerosis 2007; 192:169–176.
   PubMed Web of Science ®Google Scholar
• Sathiyapriya V, Nandeesha H, Bobby Z, Selvaraj N, Pavithran P. Perturbation of oxidant-antioxidant status in non-obese prehypertensive male subjects. J Hum Hypertens 2007; 21:176–178.
   PubMed Web of Science ®Google Scholar
• Kedziora-Kornatowska K, Czuczejko J, Pawluk H, Kornatowski T, Motyl J, Szadujkis-Szadurski L, Szewczyk-Golec K, Kedziora J. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett 2004; 9:635–641.
   PubMed Web of Science ®Google Scholar
• Tandon R, Sinha MK, Garg H, Khanna R, Khanna HD. Oxidative stress in patients with essential hypertension. Natl Med J India 2005; 18:297–299.
   PubMed Web of Science ®Google Scholar
• Parslow RA, Sachdev P, Salonikas C, Lux O, Jorm AF, Naidoo D. Association between plasma antioxidants and hypertension in a community based sample of 415 Australians aged 60–64. J Hum Hypertens 2005; 19:219–226.
   PubMed Web of Science ®Google Scholar
• Armbruster DA. Fructosamine: structure, analysis and clinical usefulness. Clin Chem 1987; 33:2153–2163.
   PubMed Web of Science ®Google Scholar
• Slatter AD, Murray M, Bailey AJ. Formation of a dihydropyridine derivative as a potential cross-link from malondialdehyde in physiological systems. FEBS Lett 1998; 421:180–184.
   PubMed Web of Science ®Google Scholar
• Slattter AD, Bolton CS, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000; 43:550–557.
   PubMed Web of Science ®Google Scholar
• Nair V, Viettri DE, Cooper CS. Degenerative chemistry of malondialdehyde – structure, stereochemistry, and kinetics of formation of enaminals from reaction with amino acids. J Am Chem Soc 1981; 103:3030–3036.
   Web of Science ®Google Scholar
• Sathiyapriya V, Nandeesha H, Bobby Z, Pavithran P, Selvaraj N, Dasse NR. Insulin resistance and enhanced protein glycation in men with prehypertension. Clin Chem Lab Med 2006; 44:1457–1461.
   PubMed Web of Science ®Google Scholar
• Kanauchi M, Kanauchi K, Hashimoto T, Saito Y. Metabolic syndrome and new category “pre-hypertension” in a Japanese population. Curr Med Res Opin 2004; 20:1365–1370.
   PubMed Web of Science ®Google Scholar
• Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Aparna A, Pavithran P. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk. Clin Exp Hypertens 2008; 30:367–374.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992; 20:38–45.
   PubMed Web of Science ®Google Scholar
• Wenger NK. Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis 2003; 46:199–229.
   PubMed Web of Science ®Google Scholar
• Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertens 1995; 25:155–161.
   PubMed Web of Science ®Google Scholar
• Sharret AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoprotein A-1 and B and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104:1108–1113.
   PubMed Web of Science ®Google Scholar
• Szapary PO, Rader DJ. The triglyceride-high-density lipoprotein axis: an important target of therapy? Am Heart J 2004; 148:211–221.
   PubMed Web of Science ®Google Scholar
• Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Rad Biol Med 2000; 28:1685–1696.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann Rev Med 1995; 46:223–234.
   PubMed Web of Science ®Google Scholar